Today: 7 February 2026
Subscribe

lon Musk’s $1 Billion Tesla Stock Buy – A Game-Changing Bet Shaking Up EV Stocks

Tesla’s October Shockwave: New EVs, Autopilot Upgrades, AI Shake-Up & Global Gambits

New Vehicles and Product Releases Tesla’s vehicle lineup is evolving rapidly. In late 2025 the automaker is rolling out a cheaper EV to broaden its market. Tesla confirmed it built “first builds of a more affordable model” in June 2025 and plans volume production in the second half of 2025ts2.tech. Musk described the new car as basically a stripped-down Model Y crossoverts2.tech – likely with a smaller battery and fewer frills to hit the mid-$30K price band (versus ~$45K for today’s base Model Y). Early reports (and spy photos) suggest it will share the Model Y’s platform under an internal
17 October 2025
·
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple’s Big October Bombshells: Vision Pro 2, M5 MacBook Surprise, and an AI Push Shaking Up Tech

M5 Chip Debuts in New MacBook Pro, iPad Pro and “Vision Pro 2” Apple has surprised fans with a late-year hardware refresh centered on its next-generation M5 processor. In lieu of a live event, Apple issued a blitz of Newsroom announcements on October 15 introducing an entry-level 14‑inch MacBook Pro, updated 11″ and 13″ iPad Pro models, and a modestly upgraded Apple Vision Pro headset – all powered by the new M5 chiptechcrunch.comtechcrunch.com. The M5 is a significant leap forward: Apple says it delivers over 4× the peak GPU performance of the previous M4 generation, and Apple SVP Johny Srouji touted that
17 October 2025
Oracle Stock Surges on $300B AI Cloud Deal – Is a Trillion-Dollar Valuation Next?

Oracle’s AI Cloud Blitz: $300B OpenAI Deal, Meta Pact, and Supercomputer Unveiled

Oracle’s Historic AI Cloud Deals Fuel Ambitions Oracle has seized center stage in the artificial intelligence race by securing eye-popping cloud contracts to host and train the world’s most advanced AI models. In a move that stunned the tech industry, OpenAI – creator of ChatGPT – agreed to spend a reported $300 billion on Oracle Cloud over five yearsreuters.com. If fully realized, it ranks as one of the largest cloud deals ever and instantly turbocharges Oracle’s cloud business. This year Oracle also inked a major partnership with Meta Platforms, which committed roughly $65 billion for Oracle’s cloud services as Meta expands its
17 October 2025
·
Nvidia’s AI Empire Unleashed: Mini Supercomputers, Mega-Deals and a Global Chip Arms Race

Nvidia’s AI Empire Unleashed: Mini Supercomputers, Mega-Deals and a Global Chip Arms Race

AI Alliances and Rivalries: OpenAI, xAI, and a $100B Power Play Nvidia’s dominance in AI computing has led to both blockbuster partnerships and fierce competition in recent weeks. The most dramatic development is Nvidia’s sweeping alliance with OpenAI – a deal valued at up to $100 billion that intertwines the leading AI chip supplier with the maker of ChatGPT ts2.tech ts2.tech. Under the agreement, announced late September, Nvidia will take a sizable (non-voting) stake in OpenAI and in return OpenAI commits to buying Nvidia’s cutting-edge GPUs to build out an unprecedented 10 gigawatts of AI supercomputing capacity ts2.tech ts2.tech. “Everything starts
17 October 2025
·
RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

Key Facts Period Price Change (Approx.) 1 day +0.5% (Oct. 17 vs Oct. 16) 5 days +0.1% (since Oct. 10) 1 month ≈ 0% (since Sept. 17) Table: RTX stock price percentage change over recent periods. Conclusion RTX Corporation (NYSE: RTX) enters late October 2025 with solid momentum: a major engine launch cleared for takeoff, booming demand for its defense systems, and an upcoming earnings report that could affirm its growth trajectory. The stock’s slight rally on Oct. 17 – bucking a broader market downturn – signals that traders are focusing on RTX’s fundamentals and news flow rather than short-term macro
17 October 2025
··
White House’s Shocking 10% Intel Stake Plan Shakes the Tech World

Intel Stock Soars on AI Hype and Big Backers – Will the Rally Last?

Intel Stock Price: Recent Moves and Momentum Intel’s share price has been on a roller-coaster in recent days, reflecting both excitement and caution. As of market close on Oct. 17, INTC traded in the high-$36 rangets2.tech, roughly flat for the week. The stock briefly spiked toward $38 earlier in the month – a new 52-week high – after reports that Intel was in talks to have AMD as a chip fabrication customerts2.tech. That October 2 report (via Semafor) sent Intel up almost 4% intradayts2.tech, but gains faded when Deutsche Bank quickly warned the stock was overextended at those levels, urging
17 October 2025
·
IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)

IBM Stock Hits Multi-Year High on AI & Quantum Hype – Can the Rally Last?

IBM’s Big 2025 Rally Powered by AI Ambitions International Business Machines (NYSE: IBM) has staged a remarkable comeback in 2025. After languishing for much of the past decade, IBM’s stock has roared back to life, reaching levels not seen in years. It briefly hit an intraday high of ~$296 in late September when news of a quantum computing feat with HSBC sparked a 5% one-day jumpts2.techts2.tech. Even with a minor dip in mid-October, IBM trades only a few percent below that peak. Year-to-date, the shares are up roughly 28% (through mid-Oct) – a huge move for such a mature tech
17 October 2025
···
Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco Rides AI Wave as Stock Nears Year-High – What’s Next for CSCO?

CSCO Stock Near 2025 Highs After Steady Climb Cisco’s stock is trading at $69 as of Friday, Oct. 17, 2025, putting it just a few dollars shy of its 1-year peakmarketbeat.com. This marks a strong run for the networking giant – shares have risen about 30% over the past year, easily outperforming the broader market. In the week leading up to Oct. 17, CSCO gained roughly 2%, reflecting optimism around the company’s recent announcements and financial results. The stock’s 12-month high is $72.55 and the low is $52.11marketbeat.com, so current prices indicate investors have driven the stock toward the upper
17 October 2025
··
Alibaba Stock Soars on AI Frenzy – Can the Rally Last?

Alibaba’s 2025 Comeback: AI Ambitions Fuel BABA Stock Rally – Will It Last?

Stock Price and Market Performance (Oct. 17 Update) Alibaba’s stock is capping off a strong week, with a notable move on October 17, 2025. The NYSE-listed BABA shares closed around $167 on Friday, recovering from early-session weakness. This roughly 3% intraday rebound came despite a sell-off in Hong Kong, where Alibaba’s secondary listing fell over 4% amid broad tech declines. Even with recent volatility, Alibaba’s U.S. stock remains near multi-year highs – up about 85–90% year-to-datets2.tech. By comparison, the NYSE Composite index is only up ~12% in 2025ts2.tech, underscoring Alibaba’s outsized rally. The stock’s momentum since spring carried it above
17 October 2025
····
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Key Facts: – Oscar Health (NYSE: OSCR) shares have surged in early October 2025, recently trading around $21–22 (up ~40% YTD)ts2.techmarketbeat.com. The stock hit about $21.50 on Oct 3 (+11% on the day) and was trading near $21.76 on Oct 14 (+6.7%)ts2.techmarketbeat.com. – Oscar announced a $410 million convertible debt offering in September 2025 to fund AI-driven technology and growth initiativests2.tech. Proceeds will back “strategic initiatives focused on AI” and expansion of member servicesbusinesswire.comts2.tech. – The company also forged a major partnership with Midwestern grocer Hy‑Vee: launching “Hy‑Vee Health with Oscar”, an employer health plan in Iowa. CEO Mark Bertolini
17 October 2025
·
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit Stock Rockets and Slumps: RDDT’s Wild Ride in 2025

Stock Volatility and Recent Moves Reddit’s stock has been highly volatile. After its monster summer rally, RDDT pulled back sharply in early October. In mid-September 2025 it briefly hit a $282.95 recordts2.tech, but profit-taking and tech-sector jitters drove it back toward the $190s by Oct 17. On Oct 17, midday trading saw RDDT around $190.44, roughly 4.3% lower for the daystockanalysis.com. (By 1:57 p.m. it was about $192.14stockanalysis.com.) Year-to-date the stock is still up roughly 244%ts2.tech, far outperforming the S&P 500 and Nasdaq indices. Since the March 2024 IPO, RDDT is up more than six-fold (600%+)ts2.techreuters.com – a blistering return
17 October 2025
SoundHound AI Stock Skyrockets 240% – Is the Voice AI Boom Just Beginning?

SoundHound AI Stock Slides 10% After CFO Cashes In – Can the 240% AI Rally Survive?

Stock Slides After CFO’s Share Sale SoundHound AI stock sank on Friday after news of insider selling, undercutting some of the recent euphoria. The company’s Chief Financial Officer, Nitesh Sharan, disclosed he sold 60,376 SoundHound shares at an average ~$21.21 (a ~$1.28 million transaction)indexbox.io. The sale, executed under a pre-arranged 10b5-1 trading plan, reduced the CFO’s direct stake by about 3.3%indexbox.io. The market reacted swiftly: SOUN fell ~6.9% in morning trading on Oct. 17 following the disclosure, and by afternoon it was trading around $18.80, roughly 9–10% below the prior day’s closeindexbox.ioindexbox.io. The timing of Sharan’s sale coincided with a broader
17 October 2025
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Stock Jumps as Outlook Brightens Gilead’s share price has been on a tear in recent weeks, reaching new highs for 2025. By mid-day October 17, GILD was up about 4.7% to roughly $123 per share Benzinga. Year-to-date, the stock has rallied nearly 47%, adding tens of billions to Gilead’s market value Stockanalysis. This far outpaces the single-digit gain of the Nasdaq Biotechnology Index over the same period Stockanalysis Invesco. Investors have cheered a string of positive catalysts: strong earnings, a fortified HIV franchise, and growing pipeline prospects. Notably, Gilead’s Q2 results in August beat expectations and prompted management to raise
17 October 2025
··
Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Stock Performance & Recent Moves: Rekor stock has surged lately on a combination of upbeat corporate news and broader tech buzz. After closing around $2.60 on Oct. 16, REKR jumped roughly 20% on Oct. 17 (trading near $3.17)tradingview.com. This continued a steep one-month rally: TS2.tech notes the shares have climbed about 73% in the past 30 daysts2.tech. This meteoric rise came as the company previewed blowout third-quarter results and rolled out new contracts. Wall Street observers say the valuation – now about 5.8× sales – appears “fair” relative to peers given Rekor’s growth outlookts2.tech. (By comparison, Rekor grew revenue ~7%
17 October 2025
·
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Stock Performance: From Slump to Sudden Surge ts2.techLiberty Energy’s stock has seen a dramatic swing in recent weeks. After grinding lower for most of 2025 – at one point down over 40% year-to-date – LBRT caught a bid in October, climbing roughly 15% during the monthts2.tech. The rally accelerated on October 17 when the company’s latest earnings sparked a burst of buying. Intraday, LBRT shares jumped into the mid-$15 range, marking a one-day gain of more than 20%. Even with that pop, Liberty’s stock is a far cry from where it started the year (above $20). The one-year total return
17 October 2025
···
Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

In sum, the mid-October “crypto Black Friday” crash has ignited a firestorm of questions about market manipulation and the fragility of trading infrastructure. Evidence of suspicious whale trades, exchange glitches, and perfectly-timed exploits suggest that the rout may have been at least partly orchestrated, rather than a natural response to bad news. Regulators are under pressure to scrutinize what really happened behind the scenes. The crypto market, meanwhile, is gingerly finding its footing again. Bitcoin’s price is well off its highs but signs of resilience – from hodlers doubling down to institutional money staying put – offer hope that the
17 October 2025
·
XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Stock Price Skyrockets on Acquisition News Shares of XORTX Therapeutics Inc. (NASDAQ: XRTX) surged on October 17, 2025 after the nano-cap biotech announced a strategic acquisition in its core therapeutic area. The stock rocketed up immediately following the morning press release, spiking up to 40% in early trading. By midday, XRTX was changing hands at just over $1.20 per share (up from around $0.86 the prior day)ragingbull.com. It eventually closed about 21% higher on Fridaytipranks.com – a dramatic move for a company that had been trading quietly near the $1 level. This rally was accompanied by an explosion in
17 October 2025
Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

FDA Setback Triggers Strategic Review Kezar Life Sciences revealed a major regulatory setback for its lead drug and immediately pivoted to consider strategic alternatives. In an October 16 press release, the South San Francisco company announced it failed to reach alignment with the U.S. Food and Drug Administration on the design of a pivotal trial for zetomipzomib in autoimmune hepatitis (AIH)ca.investing.com. The FDA abruptly canceled a Type C meeting that was scheduled for Q4 2025 to discuss Kezar’s proposed Phase 3 trial, and instead requested a new standalone study to characterize zetomipzomib’s pharmacokinetics in patients with severe liver impairmentstocktitan.netstocktitan.net. The
17 October 2025
·
Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

FDA Voucher Ignites IRON Stock Rally Disc Medicine’s stock price (NASDAQ: IRON) spiked dramatically in mid-October 2025 after news of the FDA voucher, vaulting from the mid-$70s to the low-$90s in a single daygurufocus.com. On Friday (Oct. 17), IRON opened around $85 and surged to an intraday high of $92.50 before closing at $93.00, marking a ~25% jump on the daystockanalysis.com. This leap capped a steady uptrend over the past month – the shares were trading near $60 in early September and gradually climbed into the $70s as anticipation built around bitopertin’s NDA filing and reviewstockanalysis.comstockanalysis.com. The FDA’s award of
17 October 2025
Nebius (NBIS) Stock Rockets on $17B Microsoft AI Deal – Explosive Growth & Outlook Revealed

Nebius Group (NBIS) Skyrockets 350% on AI Deal, Then Stumbles – What’s Next for This Cloud Newcomer?

Nebius Stock’s Wild 2025 Ride – From $14 to $130+ 🚀 Nebius Group’s logo on display – the AI cloud upstart has seen its stock skyrocket in 2025 amid major deals. Few stocks captured the AI frenzy of 2025 like Nebius Group. This Amsterdam-headquartered cloud upstart – born from the breakup of Russia’s Yandex – has seen its Nasdaq-listed shares soar by triple digits. Year-to-date, NBIS has climbed roughly +350%, far outpacing broader tech indicests2.tech. The stock hit an all-time high around $132-$135 in early October, a stunning jump from just ~$14 a year agots2.tech. As one analysis noted, Nebius’
17 October 2025
··
1 … 1,436 1,437 1,438 1,439 1,440 … 1,633

Stock Market Today

Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

7 February 2026
The Philadelphia Semiconductor Index jumped 5.7% to 8,048.6 on Friday, with Nvidia up 7.87% and AMD rising 8.28%. The surge followed new forecasts showing global chip sales could hit $1 trillion in 2026. Amazon expects a 50% increase in capital spending this year, fueling demand for chips. The Dow Jones crossed 50,000, helped by gains in chipmakers.
Oil stocks jump on Iran risk lift for crude — what to watch before Monday

Oil stocks jump on Iran risk lift for crude — what to watch before Monday

7 February 2026
U.S. oil stocks surged Friday as crude prices rose on renewed Middle East tensions. Exxon Mobil gained 2.0%, ConocoPhillips 2.5%, and Occidental Petroleum 2.7%. Refiners rallied after a national union deal eased strike risk, though BP’s Whiting plant faces a local dispute. Brent settled at $68.05 a barrel, up 0.74%.
Silver price rebound masks fresh stress after CME lifts margins again

Silver price rebound masks fresh stress after CME lifts margins again

7 February 2026
Spot silver surged 8.6% to $77.33 an ounce Friday after dropping below $65, but still lost over 8.7% for the week. CME Group raised margin requirements for COMEX silver futures to 18% from 15%, effective after Feb. 6. China’s UBS SDIC Silver Futures Fund hit its 10% down limit for a fifth session. Traders await key U.S. jobs and inflation data next week.
Go toTop